INVVY - Indivior to restructure axe jobs as it looks to cut costs

Opioid addiction treatment maker Indivior ([[INVVY]] -1.8%) has outlined plans to reduce costs by $60-$70M in 2021, through job cuts and restructuring.The reorganization will see a shift towards the US sales functions to focus on its Sublocade monthly anti-opioid-addiction injection and its Perseris treatment for the treatment of schizophrenia.The company said its Q3 performance has been in-line with the expectations, with the exception that Suboxone performing better than expected.Within the pipeline, the priorities include a potential treatment of alcohol and opioid use disorder.

For further details see:

Indivior to restructure, axe jobs as it looks to cut costs